CISATRA Injection 5ml

❌ Due to high demand, this product is currently out of stock. New stock will be available shortly.
👉 Click here to Buy Same Salt medicine

370.00 Original price was: ₹370.00.362.10Current price is: ₹362.10.
Out of stock

CISATRA Injection is a muscle relaxant used in hospitals during surgery and other procedures that require a person to be fully relaxed. It works by temporarily blocking nerve signals from reaching the muscles, which causes the muscles to stop moving for a short time. This helps doctors insert breathing tubes, perform operations more safely, and support controlled ventilation in patients who need help breathing. CISATRA Injection does not put a person to sleep or relieve pain, so it is always given under close medical supervision, usually along with anesthesia or sedation. Its effects are carefully monitored because it works quickly and wears off after the procedure is finished.

Out of stock
Add to wishlist
Ingredient: Brand:

Description

CISATRA Injection is a prescription medicine used in hospitals and surgical settings to produce temporary muscle relaxation. it belongs to a class of medicines called non-depolarizing neuromuscular blocking agents. these medicines are not pain relievers and do not cause sleep by themselves. instead, they work by preventing nerves from signaling muscles to contract, which makes them especially useful during procedures where complete muscle relaxation is needed, such as endotracheal intubation, mechanical ventilation, and certain surgeries.

the medicine acts at the neuromuscular junction, which is the communication point between a nerve and a muscle. normally, the nerve releases acetylcholine, a chemical messenger that attaches to receptors on the muscle and triggers contraction. CISATRA Injection blocks these receptors, so the muscle cannot respond to the nerve signal. as a result, the muscles become relaxed and movement is temporarily reduced or stopped. this effect is highly valuable in anesthesia because it helps clinicians place breathing tubes more easily, optimize surgical conditions, and improve control of patient ventilation.

CISATRA Injection is typically given by trained healthcare professionals in a controlled medical environment. it is not intended for self-administration. because it can affect the muscles needed for breathing, patients require careful monitoring, including respiratory support when appropriate. its use is especially common in anesthesiology, critical care, and emergency airway management. the medicine is selected when clinicians need a reliable, controllable, and reversible period of muscle paralysis with close monitoring of vital signs and oxygenation.

unlike sedatives or anesthetics, CISATRA Injection does not provide pain relief, anxiety relief, or unconsciousness. for that reason, it is usually combined with other medicines that provide anesthesia, sedation, and analgesia. it is important to understand that the patient may still feel pain or awareness unless those other medicines are also given. because of this, the medicine must only be used by professionals who can monitor the patient continuously and manage the airway and breathing if needed.

ingredients

  • CISATRA Injection: the active medicine that produces temporary skeletal muscle relaxation by blocking acetylcholine at the neuromuscular junction. its main role is to assist with intubation, controlled ventilation, and surgical muscle relaxation. it does not treat pain, infection, inflammation, or the underlying disease being managed; instead, it supports procedures by making muscle movement easier to control.
  • water for injection or sterile diluent components: in injectable hospital preparations, a sterile liquid medium is used to prepare and deliver the medicine safely. these components help maintain stability and allow precise administration by healthcare professionals.
  • ph-adjusting or stabilizing agents: some formulations may include small amounts of substances used to maintain the correct acidity and stability of the product during storage and use. these help preserve the medicine’s effectiveness and safety in clinical settings.

key uses

  • facilitating endotracheal intubation: CISATRA Injection helps relax the muscles of the jaw, throat, and body so that a breathing tube can be inserted more smoothly during anesthesia or emergency airway management.
  • assisting mechanical ventilation: in critically ill patients who need ventilator support, the medicine may be used to reduce muscle activity and improve synchrony with the ventilator when necessary.
  • providing muscle relaxation during surgery: it creates better operating conditions by preventing involuntary movement and easing access to the surgical area.
  • supporting procedures requiring controlled immobility: in selected situations, temporary paralysis can help clinicians perform complex medical procedures safely and accurately.

how to use

CISATRA Injection is given only by healthcare professionals, usually as an intravenous injection or infusion in a hospital, operating room, intensive care unit, or emergency setting. the dose and timing are individualized based on the patient’s age, body weight, clinical condition, other medicines being used, and the level of muscle relaxation needed. because its effect can reduce or stop breathing muscles, the patient is always monitored closely, and breathing support may be provided through assisted ventilation or a breathing tube.

this medicine is used in combination with anesthetic, sedative, and pain-control medicines when appropriate. it should never be used outside a monitored medical environment. patients receiving CISATRA Injection may need neuromuscular monitoring to help clinicians determine how strongly the medicine is working and when the muscle-relaxing effect is wearing off. recovery varies among patients, so medical staff will continue observing breathing, oxygen levels, blood pressure, and heart rate until it is safe.

if you are a patient or caregiver, do not attempt to self-administer or adjust this medicine. always follow the instructions of the anesthesiologist, intensivist, or treating physician. if you have a history of neuromuscular disease, severe liver or kidney problems, allergic reactions, or breathing issues, make sure the healthcare team is aware before treatment begins.

safety information

  • warnings: CISATRA Injection can cause profound muscle weakness, including temporary paralysis of the breathing muscles. it must only be used where airway support, oxygenation, and emergency resuscitation equipment are immediately available. because it does not cause unconsciousness or pain relief, it must be combined with appropriate anesthesia or sedation when used for surgery or procedures. patients may have prolonged effects if they have certain medical conditions or receive interacting medicines. rarely, severe allergic reactions can occur and require urgent treatment.
  • side effects: common effects include temporary muscle weakness, low blood pressure, flushing, and slower or faster heart rate depending on the individual response and clinical situation. serious side effects can include prolonged paralysis, difficulty breathing after the procedure, severe allergic reaction, bronchospasm, marked blood pressure changes, and rare but life-threatening anaphylaxis. any unexpected breathing difficulty after administration requires immediate emergency attention.
  • precautions: use extra caution in people with neuromuscular disorders such as myasthenia gravis, severe electrolyte abnormalities, major burns, severe dehydration, obesity with breathing compromise, or significant liver or kidney impairment. patients with a known history of allergic reactions to neuromuscular blocking agents should be evaluated carefully. the medicine should be used only by professionals trained in airway management and neuromuscular blockade monitoring.
  • pregnancy/breastfeeding: CISATRA Injection is used only when clearly needed during pregnancy or childbirth-related care and when the expected benefit outweighs any potential risk. it may be used in surgical or emergency settings if judged appropriate by the medical team. information in breastfeeding is limited, but because the medicine is given in hospital and has short-term use, exposure is expected to be low; however, a healthcare professional should make the final decision based on the situation.
  • interactions: other anesthetics, sedatives, opioids, magnesium, and some antibiotics can strengthen or prolong its muscle-relaxing effect. drugs that affect neuromuscular transmission may also alter its action. excessive alcohol use is generally relevant only in the broader anesthesia context, since CISATRA Injection is not taken by mouth, but alcohol history may matter when planning sedation and recovery. always tell the healthcare team about all medicines, supplements, and recent exposures before receiving it.

additional information

  • storage: store according to the manufacturer’s instructions, usually in a controlled medical storage environment away from excessive heat, light, and freezing. hospital staff should inspect the solution before use and discard any product that appears discolored, cloudy, or otherwise compromised.
  • missed dose: this medicine is not taken on a routine self-dosing schedule. if a planned hospital dose is delayed or missed, the healthcare team will decide the appropriate next step based on the procedure, patient condition, and monitoring findings.
  • overdose: too much CISATRA Injection can cause extended paralysis, including prolonged inability to breathe without assistance. this is a medical emergency and requires immediate ventilatory support, close monitoring, and continued care until the drug effect wears off. reversal strategies and supportive treatment may be considered by clinicians depending on the situation.
  • habit forming: no. CISATRA Injection is not considered habit-forming or addictive. it is a short-term hospital medicine used for specific medical procedures and does not produce dependence.

frequently asked questions

Q: what is CISATRA Injection used for?

A: CISATRA Injection is used in hospitals to temporarily relax skeletal muscles during surgery, intubation, and mechanical ventilation. it helps doctors control movement and manage the airway more safely.

Q: does CISATRA Injection put a person to sleep?

A: no. CISATRA Injection does not cause sleep or unconsciousness. it only relaxes muscles, so it is usually given with anesthesia or sedation medicines that keep the patient comfortable and unaware when needed.

Q: can CISATRA Injection stop breathing?

A: it can temporarily weaken or paralyze the muscles used for breathing, which is why it must be given in a monitored setting with ventilatory support available. this effect is expected and carefully managed by medical professionals.

Q: how quickly does CISATRA Injection work?

A: it generally starts working soon after intravenous administration, but the exact onset depends on the clinical setting, dose, and patient factors. healthcare professionals monitor the response using clinical signs and neuromuscular monitoring.

Q: how long does CISATRA Injection last?

A: its muscle-relaxing effect is temporary and duration varies with the dose, infusion rate, and patient condition. medical staff monitor recovery and continue support until normal breathing strength returns.

Q: is CISATRA Injection safe for everyone?

A: no medicine is safe for everyone. people with certain neuromuscular disorders, severe organ impairment, or a history of allergic reactions may need special assessment or alternative treatment. a healthcare professional should decide if it is appropriate.

Q: what are the most important side effects of CISATRA Injection?

A: the most important risks include temporary paralysis, breathing difficulty, low blood pressure, and rare severe allergic reactions. because of these risks, it is used only where emergency support is available.

Q: can CISATRA Injection be used at home?

A: no. it is a hospital-only medicine and must be administered by trained professionals with equipment for airway management and close monitoring.

Q: does CISATRA Injection relieve pain?

A: no. it does not reduce pain or provide anesthesia. pain control must be provided separately with appropriate medicines.

Q: what should patients tell the doctor before receiving CISATRA Injection?

A: patients should report any history of muscle disease, breathing problems, allergies to anesthetic drugs, liver or kidney problems, recent major burns, pregnancy, breastfeeding, and all current medicines or supplements.

Q: can CISATRA Injection cause allergic reactions?

A: yes. although uncommon, serious allergic reactions can occur and may include rash, swelling, wheezing, low blood pressure, or collapse. emergency treatment is needed if this happens.

Q: is CISATRA Injection the same as a sedative?

A: no. CISATRA Injection is not a sedative. it only blocks muscle contraction, so it must be paired with appropriate sedation or anesthesia when used for procedures.

Q: why is monitoring needed with CISATRA Injection?

A: monitoring is essential because the medicine can affect breathing muscles and blood pressure. clinicians use monitoring to ensure the right level of muscle relaxation and safe recovery.

Q: can other medicines make CISATRA Injection stronger?

A: yes. some antibiotics, magnesium, anesthetics, and sedatives can increase its effect or make recovery slower. the medical team checks for interactions before use.

Q: what happens if the effect of CISATRA Injection lasts too long?

A: if paralysis lasts longer than expected, the patient may need continued breathing support and observation until muscle function returns. doctors manage this in the hospital setting.

Q: is CISATRA Injection addictive?

A: no. it is not habit-forming because it is used only briefly in controlled medical situations and does not produce dependence.

Q: can a patient move or speak after CISATRA Injection?

A: during the active effect, muscle movement is greatly reduced or absent, so the patient may not be able to move or speak. the ability returns as the medicine wears off.

Q: why might CISATRA Injection be preferred in critical care?

A: it may be chosen because it offers predictable muscle relaxation and can help when strict ventilator control is needed. the decision depends on the patient’s overall condition and the clinician’s judgment.

Q: what should be done after accidental exposure or suspected overdose?

A: immediate medical attention is required. supportive care with breathing assistance and monitoring is essential until the drug effect resolves.

Q: should patients worry if they feel weak after surgery?

A: mild weakness can occur while the medicine is wearing off, but any prolonged or worsening breathing difficulty, inability to move, or unusual weakness should be reported right away to the medical team.

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.

Certified Content
Medical Disclaimer:
At Gem Pharmacy, we make every effort to provide accurate, expert-written, and thoroughly reviewed information related to medicines. However, this information should not be considered a substitute for professional medical advice, diagnosis, or treatment from a qualified doctor.

The purpose of this information is to educate users and improve communication between patients and healthcare professionals. It should not be used to diagnose or treat any condition.

Always consult a certified healthcare professional before taking any medication.
Written by
Palak
Palak
D Pharma
Reviewed by
Palak 2
Palak
D Pharma

No products in the cart.